Search

Your search keyword '"Moriarty M."' showing total 4,188 results
Start Over "Moriarty M."

Refine your results

more »

more »

more »

more »

more »

more »

more »

more »
4,188 results on '"Moriarty M."'

51. neoadjuvant therapy for borderline resectable pancreatic ductal adenocarcinoma (PDA) involving a high volume pancreatic centre in Ireland

Author

Abdul Rahman, R., primary, Bonanni, L., additional, O'Sullivan, S., additional, Greally, M., additional, Patel, A.N., additional, McHugh, J., additional, Ismail, I., additional, Alken, S., additional, Maguire, D., additional, Hoti, E., additional, Geogheghan, J., additional, Conlon, K., additional, Moriarty, M., additional, McVey, G., additional, and McDermott, R., additional

Published
2019
Full Text
View/download PDF

55. Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions.

Author

Bach S, Shovlin S, Moriarty M, Bardoni B, and Tropea D

Abstract

Rett syndrome (RTT) and Fragile X syndrome (FXS) are two monogenetic neurodevelopmental disorders with complex clinical presentations. RTT is caused by mutations in the Methyl-CpG binding protein 2 gene ( MECP2 ) altering the function of its protein product MeCP2. MeCP2 modulates gene expression by binding methylated CpG dinucleotides, and by interacting with transcription factors. FXS is caused by the silencing of the FMR1 gene encoding the Fragile X Mental Retardation Protein (FMRP), a RNA binding protein involved in multiple steps of RNA metabolism, and modulating the translation of thousands of proteins including a large set of synaptic proteins. Despite differences in genetic etiology, there are overlapping features in RTT and FXS, possibly due to interactions between MeCP2 and FMRP, and to the regulation of pathways resulting in dysregulation of common molecular signaling. Furthermore, basic physiological mechanisms are regulated by these proteins and might concur to the pathophysiology of both syndromes. Considering that RTT and FXS are disorders affecting brain development, and that most of the common targets of MeCP2 and FMRP are involved in brain activity, we discuss the mechanisms of synaptic function and plasticity altered in RTT and FXS, and we consider the similarities and the differences between these two disorders., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Bach, Shovlin, Moriarty, Bardoni and Tropea.)

Published
2021
Full Text
View/download PDF

56. Resolution of biodiversity and assemblage structure in demersal fisheries surveys: the role of tow duration

Author

Moriarty, M., Sell, A. F., Trenkel, Verena, Lynam, C. P., Burns, F., Clarke, E. D., Greenstreet, S. P. R., Mcgonigle, C., Moriarty, M., Sell, A. F., Trenkel, Verena, Lynam, C. P., Burns, F., Clarke, E. D., Greenstreet, S. P. R., and Mcgonigle, C.

Abstract

An experiment during a fisheries independent survey in the North Sea was conducted to test whether sampling effort could be reduced without a significant loss in data precision. To examine potential effects of reducing tow duration from the standard 30 min to a proposed 15 min estimates of species encounter rates, species richness, and estimates of abundance, biomass, and body size were analysed. Results show species richness estimates are lower in the short tow category. While biomass and abundance at length and body size are significantly affected by the change in tow duration, estimates of Large Fish Indicator, the Typical length and Mean-max length are not significantly affected by the regime change. The results presented here suggest that a reduction of tow duration did not optimize the resolution of biodiversity, and it may affect other survey objectives, such as, providing estimates of abundance or biomass for assessment of commercial species.

Published
2018
Full Text
View/download PDF

62. (ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis

Author

Lee, K. A., primary, Dunne, M., additional, Small, C., additional, Kelly, P. J., additional, McArdle, O., additional, O’Sullivan, J., additional, Hacking, D., additional, Pomeroy, M., additional, Armstrong, J., additional, Moriarty, M., additional, Clayton-Lea, A., additional, Parker, I., additional, Collins, C. D., additional, and Thirion, P., additional

Published
2018
Full Text
View/download PDF

64. Irish association for cancer research: Scientific meeting held in Queen’s University, Belfast, on September 23rd, 1983. The Sixth Irish Cancer Society Lecture was delivered by Professor D. G. Harnden, Director of the Paterson Labboratories, Christie Hospital and Holt Radium Institute, Manchester on “Cancer genes, chromosomes and cancer”

Author

Abram, W. P., Jones, F., McGuigan, M., Corbally, N., Malone, J. F., Mothersill, C., Seymour, C., Martin, W. M. C., Mulgrew, S., Moriarty, M., Bailey, D., Duignan, J. P., Morrissey, B., Crowe, J., Lennon, J., O’Malley, E., Atkinson, R. J., Lowry, W. S., O’Loughlin, G., Herity, N., Blake, P., Conroy, R., Buchanan, K. D., O’Hare, M. M. T., Kennedy, T. L., Hadden, D. R., Thornes, R. D., Reynolds, Maura, McCann, S. R., McCormick, Derek, Clarke, R., VandenBerg, H. W., Murphy, R. F., McCluskey, D. R., Russell, R. J., Earls, B. J. P., VandenBerg, H. W., Wilson, R., Kennedy, D. G., O’Hare, M. M. T., Huda, I., Gibbons, J. R. P., Kennedy, T. L., Buchanan, K. D., Johnston, C. F., Shaw, C., Buchanan, K. D., Headon, Bernadette B., Reen, Denis J., Kennedy, D. G., VandenBerg, H. W., Murphy, R. F., Lowry, W. S., Rottger, J., O’Reilly, D., Mullins, L., McCarthy, M., Collins, J. K., Seymour, C. B., Mothersill, Carmel, Moriarty, M., Malone, J. F., Conere, T. J., El-Badawi, M. G., Koriech, O., Horton, P. W., Gordon, L., Lowry, W. S., Wallace, Ian, and Meldrum, R. A.

Published
1984
Full Text
View/download PDF

65. Proceedings of The Irish Association for Cancer Research Meeting: Universiiy College, Galway, 21St September, 1984

Author

Corridan, J. P., Moran, M. A., Herity, B., Hilliard, N., Moriarty, M., Fennelly, J., McCambridge, M. M., Casey, M., Quigley, M., Moriarty, M., Hunt, S., Gordon, Lynn, Lowry, W. S., Moriarty, M., Prendiville, J., Raftery, H., Blake, P., Herity, B., Robinson, A., Conroy, R., Pomeroy, M., Herity, Bernadette, Murphy, J. F., Daly, Leslie, Atkinson, R. J., Pomeroy, M., Kelly, D., McCabe, M., Fennelly, J. J., Moriarty, M., Duffy, G., Duff, F., Robinson, A., Duffy, J., Reynolds, Maura, McCann, S. R., Keeling, P., Byrne, P. J., Mealy, K., Whelan, A., Feighery, C., Hennessy, T. P. J., Mealy, K., Keeling, P., Byrne, P. J., Whelan, A., Feighery, C., Hennessy, T. P. J., Duffy, M. J., O’Connell, M., Cantwell, B., Fennelly, J., O’Siorain, L., Conroy, R., Duffy, M. J., O’Ccnnel, M., Fennelly, J., O’Siorain, L., Conroy, R., Simon, J., Harrington, M. G., O’Siorain, Li, O’Briain, S., McDonnell, S., Moriarty, M., Clynes, M., Seymour, C. B., Mothersill, C., Byrne, P., Hennessy, T. P. J., Moriarty, M., Lavelle, S. M., Lomhair, M. Mac, O’Reilly, D., Mullins, E., Canty, S., Collins, J. K., Davis, J., Conroy, J., Collins, J. K., Keatinge, M. B., Collins, P. B., Duignan, J. P., Dickson, B., Johnson, A. H., McCann, A., Seymour, C., Mothersill, C., Long, A., Moriarty, M., O’Donoghue, D., Mulgrew, S., Seymour, C., Mothersill, C., Moriarty, M., Conere, T. J., Church, S. W., Lowry, Sidney, Earls, B., and Russell, R. J.

Published
1985
Full Text
View/download PDF

66. Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin.

Author

Kelly M, O'Connor R, Townsend L, Coghlan M, Relihan E, Moriarty M, Carr B, Melanophy G, Doyle C, Bannan C, O'Riordan R, Merry C, Clarke S, and Bergin C

Subjects
Adult, Aged, Aged, 80 and over, COVID-19 mortality, Critical Care statistics & numerical data, Drug Repositioning, Female, Hospitalization, Humans, Male, Middle Aged, Off-Label Use, Patient Discharge statistics & numerical data, Respiration, Artificial statistics & numerical data, Retrospective Studies, Treatment Outcome, Young Adult, Anti-Bacterial Agents adverse effects, Anti-Bacterial Agents therapeutic use, Antimalarials adverse effects, Antimalarials therapeutic use, Azithromycin adverse effects, Azithromycin therapeutic use, Hydroxychloroquine adverse effects, Hydroxychloroquine therapeutic use, COVID-19 Drug Treatment
Abstract

Aims: To assess clinical outcomes and adverse drug events in patients hospitalised with COVID-19 treated with off-label hydroxychloroquine (HCQ) and azithromycin (Az)., Methods: We performed a retrospective analysis of hospitalised patients who had a positive polymerase chain reaction test for SARS-CoV-2 and received HCQ plus Az or no targeted therapy. The primary end point was clinical improvement on day 7 defined as either hospital discharge or an improvement of 2 points on a 6-category ordinal scale. Secondary outcomes included mortality at day 28, intensive care admission, requirement for mechanical ventilation and incidence of adverse events., Results: Data from a total of 134 patients were evaluated; 82 patients received HCQ/Az and 52 patients received no targeted therapy. Clinical improvement was seen in 26.8% of patients who received HCQ/Az but this was not significant. The rates of intensive care transfer and mechanical ventilation were higher in the treatment group, but these differences were not significant. Mortality at day 28 was significantly higher in the treatment group (P = .03). Hypoglycaemia elevated liver function tests and QT prolongation were monitored in both groups. The risk of QT prolongation was significantly higher in the treatment group. Treatment was stopped early in 6 (7.3%) patients due to adverse events., Conclusion: Although patients who received HCQ/Az were more severely ill the administration of these repurposed drugs did not result in clinical improvement and was associated with a significant increase in toxicity. This descriptive study highlights the importance of monitoring all repurposed agents for adverse events., (© 2020 The British Pharmacological Society.)

Published
2021
Full Text
View/download PDF

67. Application of the navigation guide systematic review methodology to evaluate prenatal exposure to particulate matter air pollution and infant birth weight.

Author

Uwak I, Olson N, Fuentes A, Moriarty M, Pulczinski J, Lam J, Xu X, Taylor BD, Taiwo S, Koehler K, Foster M, Chiu WA, and Johnson NM

Subjects
Adult, Birth Weight, Environmental Exposure analysis, Female, Humans, Infant, Infant, Newborn, Maternal Exposure adverse effects, Particulate Matter analysis, Pregnancy, Air Pollutants analysis, Air Pollutants toxicity, Air Pollution adverse effects, Air Pollution analysis, Prenatal Exposure Delayed Effects epidemiology
Abstract

Low birth weight is an important risk factor for many co-morbidities both in early life as well as in adulthood. Numerous studies report associations between prenatal exposure to particulate matter (PM) air pollution and low birth weight. Previous systematic reviews and meta-analyses report varying effect sizes and significant heterogeneity between studies, but did not systematically evaluate the quality of individual studies or the overall body of evidence. We conducted a new systematic review to determine how prenatal exposure to PM 2.5 , PM 10 , and coarse PM (PM 2.5-10 ) by trimester and across pregnancy affects infant birth weight. Using the Navigation Guide methodology, we developed and applied a systematic review protocol [CRD42017058805] that included a comprehensive search of the epidemiological literature, risk of bias (ROB) determination, meta-analysis, and evidence evaluation, all using pre-established criteria. In total, 53 studies met our inclusion criteria, which included evaluation of birth weight as a continuous variable. For PM 2.5 and PM 10 , we restricted meta-analyses to studies determined overall as "low" or "probably low" ROB; none of the studies evaluating coarse PM were rated as "low" or "probably low" risk of bias, so all studies were used. For PM 2.5 , we observed that for every 10 µg/m 3 increase in exposure to PM 2.5 in the 2nd or 3rd trimester, respectively, there was an associated 5.69 g decrease (I 2 : 68%, 95% CI: -10.58, -0.79) or 10.67 g decrease in birth weight (I 2 : 84%, 95% CI: -20.91, -0.43). Over the entire pregnancy, for every 10 µg/m 3 increase in PM 2.5 exposure, there was an associated 27.55 g decrease in birth weight (I 2 : 94%, 95% CI: -48.45, -6.65). However, the quality of evidence for PM 2.5 was rated as "low" due to imprecision and/or unexplained heterogeneity among different studies. For PM 10 , we observed that for every 10 µg/m 3 increase in exposure in the 3rd trimester or the entire pregnancy, there was a 6.57 g decrease (I 2 : 0%, 95% CI: -10.66, -2.48) or 8.65 g decrease in birth weight (I 2 : 84%, 95% CI: -16.83, -0.48), respectively. The quality of evidence for PM 10 was rated as "moderate," as heterogeneity was either absent or could be explained. The quality of evidence for coarse PM was rated as very low/low (for risk of bias and imprecision). Overall, while evidence for PM 2.5 and course PM was inadequate primarily due to heterogeneity and risk of bias, respectively, our results support the existence of an inverse association between prenatal PM 10 exposure and low birth weight., (Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Published
2021
Full Text
View/download PDF

70. A preliminary assessment of indirect impacts on aquaculture species health and welfare in Scotland during COVID-19 lockdown.

Author

Murray AG, Ives SC, Smith RJ, and Moriarty M

Abstract

COVID-19 led to sudden changes in human activities, mainly due to restrictive measures required to supress the virus. We assess the preliminary evidence for impacts on animal health and welfare in Scottish aquaculture, a key economic activity in remoter areas of the country. We summarise the industry structure, explore pathways of vulnerability to aquatic animal disease within a One Health framework that may be accentuated by impacts of COVID-19, and use basic routine data collection on the key welfare indicators of salmon mortality and parasitic sea lice counts. The indicators were published on schedule and provide no evidence of gross impact on health and welfare, at least for salmon, during the period of intensive lockdown restrictions in Scotland. Longer term effects cannot be ruled out and we do not assess impacts on the economic or social aspects of aquaculture production., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2021 Published by Elsevier Ltd.)

Published
2021
Full Text
View/download PDF

71. Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo.

Author

Coleman O, Henry M, O'Neill F, Roche S, Swan N, Geoghegan J, Conlon K, McVey G, Moriarty M, Meleady P, and Clynes M

Subjects
Aged, Aged, 80 and over, Carcinoma, Pancreatic Ductal pathology, Cell Line, Tumor, Chromatography, Liquid methods, Humans, Mass Spectrometry methods, Middle Aged, Pancreas metabolism, Pancreas pathology, Pancreatic Neoplasms pathology, Carcinoma, Pancreatic Ductal metabolism, Pancreatic Neoplasms metabolism, Proteome metabolism, Proteomics methods
Abstract

Objectives: A limited repertoire of good pancreatic ductal adenocarcinoma (PDAC) models is one of the main barriers in developing effective new PDAC treatments. We aimed to characterize 6 commonly used PDAC cell lines and compare them with PDAC patient tumor samples using proteomics., Methods: Proteomic methods were used to generate an extensive catalog of proteins from 10 PDAC surgical specimens, 9 biopsies of adjacent normal tissue, and 6 PDAC cell lines. Protein lists were interrogated to determine what extent the proteome of the cell lines reflects the proteome of primary pancreatic tumors., Results: We identified 7973 proteins from the cell lines, 5680 proteins from the tumor tissues, and 4943 proteins from the adjacent normal tissues. We identified 324 proteins unique to the cell lines, some of which may play a role in survival of cells in culture. Conversely, a list of 63 proteins expressed only in the patient samples, whose expression is lost in culture, may place limitations on the degree to which these model systems reflect tumor biology in vivo., Conclusions: Our work offers a catalog of proteins detected in each of the PDAC cell lines, providing a useful guide for researchers seeking model systems for PDAC functional studies.

Published
2020
Full Text
View/download PDF

72. Proteomic analysis of pancreatic ductal adenocarcinoma.

Author

Meleady P, Abdul Rahman R, Henry M, Moriarty M, and Clynes M

Subjects
Adenocarcinoma pathology, Biomarkers, Tumor genetics, Exosomes genetics, Gene Expression Regulation, Neoplastic genetics, Humans, Mass Spectrometry, Pancreatic Neoplasms pathology, Adenocarcinoma genetics, Pancreatic Neoplasms genetics, Proteins genetics, Proteomics
Abstract

Introduction: Pancreatic ductal adenocarcinoma (PDAC), which represents approximately 80% of all pancreatic cancers, is a highly aggressive malignant disease and one of the most lethal among all cancers. Overall, the 5-year survival rate among all pancreatic cancer patients is less than 9%; these rates have shown little change over the past 30 years. A more comprehensive understanding of the molecular mechanisms underlying this complex disease is crucial to the development of new diagnostic tools for early detection and disease monitoring, as well as to identify new and more effective therapeutics to improve patient outcomes., Area Covered: We summarize recent advances in proteomic strategies and mass spectrometry to identify new biomarkers for early detection and monitoring of disease progression, predict response to therapy, and to identify novel proteins that have the potential to be 'druggable' therapeutic targets. An overview of proteomic studies that have been conducted to further our mechanistic understanding of metastasis and chemotherapy resistance in PDAC disease progression will also be discussed., Expert Commentary: The results from these PDAC proteomic studies on a variety of PDAC sample types (e.g., blood, tissue, cell lines, exosomes, etc.) provide great promise of having a significant clinical impact and improving patient outcomes.

Published
2020
Full Text
View/download PDF

73. Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression.

Author

Thirion PG, Dunne MT, Kelly PJ, Flavin A, O'Sullivan JM, Hacking D, Sasiadek W, Small C, Pomeroy MM, Martin J, McArdle O, Parker I, O'Sullivan LS, Shannon AM, Clayton-Lea A, Collins CD, Stevenson MR, Alvarez-Iglesias A, Armstrong JG, and Moriarty M

Subjects
Adult, Aged, Aged, 80 and over, Female, Humans, Ireland epidemiology, Male, Middle Aged, Radiotherapy adverse effects, Risk Factors, Spinal Cord Compression pathology, Spinal Cord Neoplasms pathology, Treatment Outcome, Dose Fractionation, Radiation, Spinal Cord Compression radiotherapy, Spinal Cord Neoplasms radiotherapy
Abstract

Background: The optimal EBRT schedule for MSCC is undetermined. Our aim was to determine whether a single fraction (SF) was non-inferior to five daily fractions (5Fx), for functional motor outcome., Methods: Patients not proceeding with surgical decompression in this multicentre non-inferiority, Phase 3 trial were randomised to 10 Gy/SF or 20 Gy/5Fx. A change in mobility from baseline to 5 weeks for each patient, was evaluated by a Modified Tomita score: 1 = 'Walk unaided', 2 = 'With walking aid' and 3 = 'Bed-bound'. The margin used to establish non-inferiority was a detrimental change of -0.4 in the mean difference between arms., Results: One-hundred and twelve eligible patients were enrolled. Seventy-three patients aged 30-87 were evaluated for the primary analysis. The 95% CI for the difference in the mean change in mobility scores between arms was -0.12 to 0.6. Since -0.4 is not included in the interval, there is evidence that 10 Gy/SF is non-inferior to 20 Gy/5Fx. One grade 3 AE was reported in the 5Fx arm. Twelve (26%) patients in the 5Fx arm had a Grade 2-3 AE compared with six (11%) patients in the SF arm (p = 0.093)., Conclusion: For mobility preservation, one 10-Gy fraction is non-inferior to 20 Gy in five fractions, in patients with MSCC not proceeding with surgical decompression., Clinical Trial Registration: Cancer Trials Ireland ICORG 05-03; NCT00968643; EU-20952.

Published
2020
Full Text
View/download PDF

74. PV-0281: (ICORG 05-03): Radiotherapy in malignant spinal cord compression; The quality of life analysis

Author

Lee, K., primary, Small, C., additional, Kelly, P., additional, McArdle, O., additional, O'Sullivan, J., additional, Hacking, D., additional, Pomeroy, M., additional, Stevenson, M., additional, Armstrong, J., additional, Moriarty, M., additional, Dunne, M., additional, Clayton-Lea, A., additional, Parker, I., additional, Collins, C., additional, and Thirion, P., additional

Published
2016
Full Text
View/download PDF

78. Proceedings of meeting of Irish Association for Cancer Research May 16/17, 1985

Author

Doyle, C. T., McCann, J. P., Ardill, J. E. S., Johnston, C. F., McKee, C. M., Stevenson, H. M., Gibbons, J. R., Buchanan, K. D., Collins, P. B., Johnson, A. H., Duignan, J. P., Brady, K., Bouchier-Hayes, D., Reynolds, Maura, McCann, S. R., Mulgrew, S., Mothersill, C., Moriarity, M., Shine, Helen, Collins, J. K., Thornes, R. D., Clarke, R., Moorwood, Janet, van den Berg, H. W., Nelson, J., Murphy, R. F., Hickey, Dorinda, McCann, Shaun R., Melinn, M., Kennedy, D. G., Dickson, G. R., McCann, A., Seymour, C. B., Afdhal, N., O’Donoghue, D. P., Malone, J. F., Moriarty, M., Ardill, Joy, Shaw, C., Casey, M., Conroy, R., Daly, L., Fennelly, J., Herity, P., Hilliard, N., McCambridge, M., Walsh, Ena, Smyth, Honor, Conere, T. J., Church, S., Lowry, W. S., Dooley, Margaret, and Clynes, Martin

Published
1986
Full Text
View/download PDF

79. Irish association for cancer research Proceedings of 23rd Annual Meeting held in Cork, May, 1966

Author

McCann, S. R., Farrell, D., McDonnell, S., Neenan, S., Moriarty, M., Lynch, V., Kelehan, P., Clynes, M., O’Boyle, C., Herity, B., Hilliard, N., Houston, R. F., Cremin, M., Clarke, R., Nelson, J., Murphy, R. F., Mothersill, Carmel, Seymour, C. B., Hennessy, T. P., McCann, A., Afdhal, N., O’Donoghue, D., O’Byrne, P., Johnson, A. H., Collins, P. B., Duignan, J. B., Bouchier-Hayes, D., Atkinson, R. J., Carney, D. N., Teeling, Mary T., Coughlan, M. B., O’Neill, H., Ennis, J. T., Duffy, M. J., O’Grady, P., Devaney, D., O’Siorain, L., Lijnen, H. R., Daly, M., O’Meara, A., Hallinan, F. M., O’Sullivan, G., Kiely, D., Lee, G., Clifford, Concepta A., Headon, D. R., Casey, B., Pratt, I., Ryan, M. P., and Carney, D.

Published
1987
Full Text
View/download PDF

81. Irish association of rheumatology and rehabilitation: Proceedings of the meeting of the irish association of rheumatology and rehabilitation, held on Friday, 9th November, 1984

Author

Comerford, F. R., Reeves, Anthony, Bresnihan, Barry, Gannon, M., Barton, J., Burke, J., Bulger, K., Casey, E., Fitzpatrick, D., Temperley, I. J., Thompson, R. N., Edelman, J., Watts, C., Esdaile, J., Russell, A. S., Thompson, R. N., Wardman, P., Stanley, J. K., Newton, P., Swinburn, W. R., Smith, P., Burke, M., Swinson, D. R., Sarsfield, P., Cafferkey, M., O’Carroll, P., O’Byrne, H., Jagoe, W. S., Casey, E. B., Hassan, J., Whelan, C. A., Colohan, H., Gannon, M., Bloomfield, F. J., Bresnihan, B., Feighery, C., Malone, D. E., McCormick, P. A., Long, A., Jones, B., Bresnihan, B., Molony, J., O’Donoghue, D. P., Hanly, J., Hassan, J., Moriarty, M., Whelan, A., Feighery, C., Casey, E., Molony, J., Bresnihan, B., Coughlan, R. J., Crisp, A. J., Hazleman, B. L., Parr, G., Page Thomas, D. P., Fay, A. C., Trudgett, A., McCrea, J. D., Kirk, F., Thompson, J. M., Mitchell, E. S., Boyd, M. J. W., Roberts, S. D., and McNeill, T. A.

Published
1985
Full Text
View/download PDF

83. Irish Association for Cancer Research: Proceedings of the Scientific Meeting held in the Royal College of Surgeons, Dublin on September 25th and 26th, 1981.

Author

O’Hare, M. M. T., Sloan, J. M., Buchanan, D., Herity, B., Murphy, J., Moriarty, M., Bourke, G. J., Daly, L., Atkinson, R. J., Lowry, W. S., Dunne, J., Darragh, A., Brick, I., McCann, S. R., Whelan, C. A., Breslin, B., Temperley, I. J., Fennelly, J. J., Cantwell, B., Jones, M., Phillips, Jack, Sikora, Karol, Reynolds, M., M’cCann, S. R., O’Connell, M., McDonnell, L., Connolly, E., Duffy, M. J., Clark, R., Van den Berg+, H. W., Murphy, R. F., McCarthy, M., Cotter, J., Mullins, L., Collins, J. K., Gordon, Lynn, O’Loughlin, G., Clynes, Martin M., Moriarty, Michael J., Lavelle, S. M., Maclomhair, Maura, Hannigan, Bernadette, Johnson, Alan, Collins, Patrick, Moriarty, Michael, Al-Sader, Mahomed, Devery, Rosaleen, Walsh, Ena, Smyth, Honor, Corrigan, Antonia, Ryan, C., Mothersill, C., and Seymour, C.

Published
1982
Full Text
View/download PDF

84. Royal Academy of Medicine in Ireland Section of Surgery Proceedings of the Section of Surgery, 24th April 1987

Author

McDermott, E. W. M., Barron, E. T., Smyth, P. P. A., O’Higgins, N. J., Gillen, P., Keeling, P., Hennessy, T. P. J., Gawley, W. F., Johnson, A. H., Collins, P. B., Osborne, D. H., Gorey, T. F., Lane, B. E., Collins, P. G., O’Brien, A., Seymour, C., Mothersill, C., Cusack, A., Moriarty, M., Butler, M. R., McEntee, G. P., Leahy A. L., Ryan P. C., Catell, D., Dervan P. A., McGheeney, K., Fujimoto, Takao, Grace, P. A., Augustine, S., Lynch, G., Creagh, T., McLoughlin, F., Broe, P., Bouchier-Hayes, D., Issa, M. M., Tanner, W. A., Burke, P. E., Harvey, C. F., Murphy, L. M., Gervin, C. A., Greenfield, L. J., O’Connell, P. R., Pemberton, J. H., and Kelly, K. A.

Published
1987
Full Text
View/download PDF

85. Irish society of rheumatology and rehabilitation: Meeting held on Friday, 25th November, 1983

Author

Taggart, A. J., Desai, S. M., Iveson, J. M., Verow, P. W., Tolan, M. J., Comerford, F. R., Bresnlhan, Barry, FitzGerald, Oliver, Masterson, James, Templeton, J., Graham, K., Roberts, Stanley, Hassan, J., Hanly, J., Whelan, A., Feighery, C., Bresnihan, B., Casey, E., Colclough, M., Freyne, P., Murphy, A., McNeill, T. A., Shirodaria, P. V., Price, S., Thompson, J., Fay, A., Roberts, S. D., Frazer, Hilary E., Wisdom, G. B., McCrea, J. D., Boyd, M. W. J., Moriarty, M., and Molony, J.

Published
1984
Full Text
View/download PDF

91. All-Ireland social medicine meeting

Author

Graham, Ian M., Hickey, Noel, Daly, Leslie, Mulcahy, Risteard, Doyle, Y., Conroy, R., Mulcahy, R., Donnelly, M. D. I., Toner, Paula, Nugent, T., Anderson, D., Chadwick, E., Turkington, E., Varma, M. P. S., Graham, I., Comerford, D., Shelley, E., Daly, L., Gibney, M., Hickey, N., Kilcoyne, D., O’Dwyer, T., Radic, A., Conroy, R., Herity, B., Fennelly, J., Hilliard, N., Moriarty, M., Gavin, A. T., Telford, A. M., Lowry, G., MacKenzie, G., Bridges, J., Nevin, N., Blaney, R., McDonnell, Maura, Corridan, J. P., Doyle, C. T., Allwright, S., Sadek, F., Kirke, P. N., Molloy, A. M., Weir, D. G., Scott, J. M., Hillary, I., Evans, A. E., Condren, L., Sinclair, H., Tohani, V. K., Dean, G., and Elian, M.

Published
1987
Full Text
View/download PDF

96. Irish Society of Gastroenterology: Proceedings of the spring 1982 meeting of the Irish Society of Gastroenterology

Author

O’Grady, J. G., Cryan, E. M., Stevens, F. M., McNicholl, B., Fottrell, P., O’Gorman, T. A., McCarthy, C. F., Duignan, J. P., Power, M., Heffernan, S. J., O’Malley, E., Robinson, A. R., Speekenbrink, A. B. J., O’Moore, R. R., Keane, C. T., Weir, D. G., Gaffney, P. R., Gleeson, D., Hall, J., Brady, M. P., Ward, K., O’Connor, F. A., Bradley, B., O’Farrelly, C., Kelly, J., Thompson, A., McDonald, G., McKeever, U., Feighery, C., Kelleher, D., Whelan, C. A., Steel, Linda, McBriar, Deborah L, Erwin, Claire, McMaster, Dorothy, Love, A. H. G., Cunningham, F. O., Lavelle, S. M., O’Beirn, S., Given, H. F., Keane, P., Craven, Ciaran, Gallagher, Charles, Spencer, Susan, Crowe, John, McKeever, Una, Kelly, D., Kelly, D. A., O’Donnell, N., Mello’s, J., O’Moore, R. R., Egan, E. L., O’Riordan, M., Bourke, G., Neale, G., O’Donohue, D., Mooney, P. A., McLoughlin, D. M., Walters, J. M., O’Donoghue, D. P., Moriarty, M., Smith, M., Gillatt, A., and Moss, B.

Published
1984
Full Text
View/download PDF

97. Book reviews

Author

Coakley, J. B., Kernan, R. P., Fitzgerald, Oliver, Jessop, W. J. E., Gregg, Thomas M., Nelson, H. G., Henderson, H. J. R., Walsh, Anthony, Walsh, Anthony, O’Brien, Brendan, Walsh, Anthony, Doyle-Kelly, W., Bourke, Geoffrey J., Mulcahy, Risteard, Cross, Finbarr H., Baxter, J. T., Byrnes, C. K., Boggust, W. A., Boggust, W. A., Brady, Gerard, Cahalane, S. F., Ryan, Max, Kebnan, Roderick P., Nelson, H. G., Fenelon, Eric, Timoney, F. J., Moriarty, M. A., and McCollum, Stanley T.

Published
1965
Full Text
View/download PDF

99. Book reviews

Author

O’Donovan, D. K., O’Farrell, P. T., Malone, J. P., Roden, D., Nash, M., Moriarty, M., Douglas, Sholto, Werner, L., Mulcahy, R., Kirker, J. G., McCormack, M., Towers, R. P., Meenan, F. O. C., McVey, H., Boland, S. J., and O’Connor, M. H.

Published
1957
Full Text
View/download PDF

100. Book reviews

Author

Hingerty, D., Somerville-Large, L. B., Mulcahy, R., Daly, H. W., Roche, T. F., Micks, R. H., Henry, F. J., Kernan, R. P., Holland, P. D. J., Donovan, D. E., Weir, D. G., Devlin, J., O'Donovan, D. K., Cahalane, S. F., Pringle, Brian, Moriarty, M. A., O'Morchoe, C. C. C., Cherry, J. C., Roe, P. F., O'Shea, Michael J., Steen, R. E., Verling, W. H., and Lyons, J. B.

Published
1965
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results